St. Joseph’s Healthcare Hamilton

Running trials

• Not yet recruiting

  3-Dimensional Virtual Reality Modelling With Intravascular Indocyanine Green Fluorescence Mapping for Targeted Pulmonary Segmental Resection Trial

  NCT06638125· Phase 1/2· St. Joseph's Healthcare Hamilton· Source

• Not yet recruiting

  Totally Robotic Versus Surgeon-Assisted Robotic Lung Resection For Early-Stage NSCLC

  NCT06348030· St. Joseph's Healthcare Hamilton· Source

• Recruiting

  Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder

  NCT07213492· McMaster University· Source

• Recruiting

  Multiprofen-CC to Reduce Pain in Hand Arthritis

  NCT06966206· Phase 3· St. Joseph's Healthcare Hamilton· Source

• Recruiting

  Canadian Consortium on Airway Mucus Occlusions in Asthma, COPD and Chronic Cough

  NCT06858748· McMaster University· Source

• Recruiting

  Resolving Early Life Stress: Psychotherapy Outcomes and Neurobiology in Complex Depression

  NCT07250893· St. Joseph's Healthcare Hamilton· Source

• Recruiting

  A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

  NCT07219173· Phase 2· Eli Lilly and Company· Source

• Recruiting

  Therapeutic Relevance of Abnormal Airway Morphology in Asthma

  NCT06970080· Phase 4· McMaster University· Source

• Recruiting

  The Development, Safety, and Feasibility of an Artificial Intelligence-Powered Platform (NodeAI) for Real-Time Prediction of Mediastinal Lymph Node Malignancy During Endobronchial Ultrasound Staging for Lung Cancer

  NCT06540196· McMaster University· Source

• Active, not recruiting

  Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease

  NCT06747572· Vertex Pharmaceuticals Incorporated· Source

• Recruiting

  DETECTion of PeriOperative Atrial Fibrillation After Noncardiac Surgery

  NCT06519747· Population Health Research Institute· Source

• Recruiting

  A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

  NCT06545955· Phase 3· Ferring Pharmaceuticals· Source

• Recruiting

  Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

  NCT06510374· Phase 3· Ferring Pharmaceuticals· Source

• Active, not recruiting

  A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

  NCT06238622· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  Early Diagnosis and Treatment of Undiagnosed Asthma or COPD: THE UCAP 2 TRIAL

  NCT06392776· Ottawa Hospital Research Institute· Source

• Active, not recruiting

  A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

  NCT06329401· Phase 2· Avalyn Pharma Inc.· Source

• Active, not recruiting

  The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and Cannabidiol

  NCT05742724· Phase 1· McMaster University· Source

• Active, not recruiting

  Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis

  NCT06046222· Phase 2· NS Pharma, Inc.· Source

• Recruiting

  Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  NCT05943535· Phase 3· United Therapeutics· Source

• Recruiting

  Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients

  NCT05829317· Phase 4· Dr. Stephanie Sibley· Source

• Recruiting

  NSCLC Liquid Biopsies and Exhaled VOC

  NCT06707519· St. Joseph's Healthcare Hamilton· Source

• Recruiting

  VIrtual Care To Improve Outcomes and RecoverY From Heart Failure Hospitalization

  NCT05724433· Population Health Research Institute· Source

• Enrolling by invitation

  Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

  NCT04905693· Phase 3· United Therapeutics· Source

• Recruiting

  Sputum-guided Treatment With Comprehensive Care Management in COPD - A Randomized-controlled Trial

  NCT04890938· McMaster University· Source

• Active, not recruiting

  Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)

  NCT05248646· Phase 3· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

• Active, not recruiting

  A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP)

  NCT05031780· Phase 2/3· Agios Pharmaceuticals, Inc.· Source

• Recruiting

  Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study

  NCT04973397· Centre hospitalier de l'Université de Montréal (CHUM)· Source

• Active, not recruiting

  A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

  NCT04849728· Phase 3· Inventiva Pharma· Source

• Active, not recruiting

  A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

  NCT07218029· Phase 3· Merck Sharp & Dohme LLC· Source

• Active, not recruiting

  Robot-Assisted Partial Knee Replacement Versus Standard Total Knee Replacement

  NCT04378049· McMaster University· Source

• Active, not recruiting

  Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)

  NCT04070209· Phase 2· Sir Mortimer B. Davis - Jewish General Hospital· Source

• Recruiting

  Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

  NCT03573089· The University of Queensland· Source

• Recruiting

  Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress

  NCT03968393· Phase 4· Population Health Research Institute· Source

• Active, not recruiting

  Mean Visual Acuity Changes Following Five Injections of Aflibercept

  NCT02645266· McMaster University· Source

• Active, not recruiting

  Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma

  NCT02811861· Phase 3· Eisai Inc.· Source

• Recruiting

  Near-Infrared Fluorescence Guided Robotic Pulmonary Segmentectomy for Early Stage Lung Cancer

  NCT02570815· Phase 1· St. Joseph's Healthcare Hamilton· Source

• Active, not recruiting

  Robotic Lobectomy vs. Thoracoscopic Lobectomy for Early Stage Lung Cancer: RCT

  NCT02617186· St. Joseph's Healthcare Hamilton· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer5 recruiting
• Asthma4 recruiting
• Atrial fibrillation3 recruiting
• COPD3 recruiting
• Bladder cancer2 recruiting
• Idiopathic pulmonary fibrosis2 recruiting
• Bipolar disorder1 recruiting
• Chronic kidney disease1 recruiting
• Depression1 recruiting
• Heart failure1 recruiting
• Osteoarthritis1 recruiting
• Schizophrenia1 recruiting
• Stroke1 recruiting

Closed trials

• Withdrawn

  3-point vs 6-point GNRFA for Chronic KOA

  NCT05930756· McMaster University· Source

• Completed

  Inflammation REduction to Prevent cArdiovascular Injury in Renal Disease (REPAIR)

  NCT06203977· Phase 2· Hamilton Health Sciences Corporation· Source

• Completed

  Multiprofen-CC™ to Reduce Pain After Total Knee Arthroplasty

  NCT06202989· Phase 3· KAZM Pharmaceuticals Inc.· Source

• Completed

  Cannabinoids as a Treatment for Insomnia in Major Depression

  NCT05041647· Phase 2· St. Joseph's Healthcare Hamilton· Source

• Completed

  Cannabinoids vs. Placebo on Persistent Post-surgical Pain Following TKA: A Pilot RCT

  NCT03825965· Phase 3· McMaster University· Source

• Completed

  Deep rTMS for Depression in Older Adults

  NCT05855850· St. Joseph's Healthcare Hamilton· Source

• Completed

  Signia Stapler Versus Vessel Sealer Extend Energy Device With SureForm Stapling in Robotic-Assisted Segmentectomy

  NCT05727735· St. Joseph's Healthcare Hamilton· Source

• Completed

  Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder

  NCT05098574· Phase 2· St. Joseph's Healthcare Hamilton· Source

• Completed

  Aging, Mobility and Chronic Low Back Pain

  NCT05167877· McMaster University· Source

• Completed

  A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms

  NCT05559580· Phase 2· Boehringer Ingelheim· Source

• Completed

  A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321069· Phase 3· Boehringer Ingelheim· Source

• Terminated

  NIF-Guided RAMIE Using ICG Versus OTE Feasibility RCT

  NCT04938973· St. Joseph's Healthcare Hamilton· Source

• Completed

  Opioid Reduction in Orthopaedic Surgery (OREOS) - Knees

  NCT04968132· Kim Madden· Source

• Completed

  A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness

  NCT05014672· Phase 2· Calliditas Therapeutics Suisse SA· Source

• Completed

  Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis

  NCT05130970· Phase 2· CSL Behring· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

  NCT05037929· Phase 2· Genentech, Inc.· Source

• Completed

  Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator

  NCT05716334· McGill University Health Centre/Research Institute of the McGill University Health Centre· Source

• Completed

  Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

  NCT04708782· Phase 3· United Therapeutics· Source

• Terminated

  A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment

  NCT04338269· Phase 3· Hoffmann-La Roche· Source

• Completed

  PSMA-PET Registry for Recurrent Prostate Cancer

  NCT03718260· London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's· Source

Conditions

Diseases this institution publishes on or runs trials for.

• ANCA-associated vasculitis5 works · 2 trials